FDA NDC Directory · JSON-LD · Markdown

lisdexamfetamine dimesylate

NDC 47781-562 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerAlvogen Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA214547
Dosage form / routeCAPSULE · ORAL
Active ingredientsLISDEXAMFETAMINE DIMESYLATE (10 mg/1)
Marketing started20230825
Package count1

External sources

Source: openFDA. Public-domain (CC0).